A detailed history of Dark Forest Capital Management LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 16,105 shares of ALT stock, worth $108,547. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,105
Holding current value
$108,547
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.22 - $13.81 $132,383 - $222,410
16,105 New
16,105 $163,000
Q3 2023

Nov 13, 2023

BUY
$2.4 - $3.45 $65,304 - $93,874
27,210 Added 13.39%
230,353 $598,000
Q2 2023

Aug 14, 2023

BUY
$3.45 - $5.97 $549,267 - $950,471
159,208 Added 362.37%
203,143 $717,000
Q1 2023

May 12, 2023

BUY
$4.19 - $16.83 $184,087 - $739,426
43,935 New
43,935 $185,000
Q3 2022

Nov 14, 2022

BUY
$10.67 - $22.41 $18,096 - $38,007
1,696 New
1,696 $22,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $330M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.